MYP_020679
LP-70
Antimicrobial
Antiviral
▸
Anti-HIV
▸
Antiviral
▸
Antiviral mechanism
▸
not Standard
31 amino acids
-
contains X representing unresolved or non-standard residue
INNYTSLIEELIKKSEEQQKKNEEELKKLEX
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available: incomplete physicochemical profile.
- Molecular Weight
- Not available
- Isoelectric Point (pI)
- Not available
- Net Charge (pH 7.0)
- Not available
- GRAVY Index
- Not available
- Boman Index
- Not available
- Instability Index
- Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Amino Acid Composition
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0257644
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 31 is Lys-C16 (palmitic acid)
Bio-Activity Profile
HIV-1 NL4-3; TZM-bl cells
21±4 pM
IC50; single-cycle pseudovirus infection assay
RECORD: Rec_0276074
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 31 is Lys-C16 (palmitic acid)
Bio-Activity Profile
HIV-1 JRCSF; TZM-bl cells
30±10 pM
IC50; single-cycle infection assay
RECORD: Rec_0319888
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 31 is Lys-C16(palmitic acid)
Bio-Activity Profile
Anti-HIV-1
Fusion inhibition
HIV-1 JRCSF | TZM-bl cells
0.00003±0.00001 μM
IC50
Mammalian: 20 h; Yeast: 30 min; E. coli: >10 h
RECORD: Rec_0380350
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 31 is Lys-C16(palmitic acid)
Bio-Activity Profile
Anti-HIV-1
Fusion inhibition
HIV-1 HXB2 | TZM-bl cells
0.000025±0.000003 μM
IC50
Mammalian: 20 h; Yeast: 30 min; E. coli: >10 h
RECORD: Rec_0401338
REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 31 is Lys-C16 (palmitic acid)
Bio-Activity Profile
HIV-1 HXB2; TZM-bl cells
25±3 pM
IC50; cell-cell fusion assay
Showing 5 records · Page 2 of 2